CardioComm Solutions, Inc.
EKG.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -45.31% | -48.07% | -55.21% | -26.56% | 69.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -45.31% | -48.07% | -55.21% | -26.56% | 69.65% |
| Cost of Revenue | -94.44% | -75.00% | -97.76% | -80.06% | -37.93% |
| Gross Profit | -43.36% | -46.94% | -35.01% | 39.59% | 82.42% |
| SG&A Expenses | -30.71% | -7.70% | 2.47% | 76.07% | 21.50% |
| Depreciation & Amortization | 23.81% | 13.33% | -5.45% | -38.10% | -17.65% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.86% | -9.62% | -27.62% | -0.87% | 16.15% |
| Operating Income | -472.00% | -768.12% | -310.76% | -144.66% | 90.96% |
| Income Before Tax | -154.71% | -2,065.38% | 188.03% | -50.12% | 56.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -154.71% | -2,065.38% | 188.03% | -50.12% | 56.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -154.71% | -2,065.38% | 188.03% | -50.12% | 56.61% |
| EBIT | -472.00% | -768.12% | -310.76% | -144.66% | 90.96% |
| EBITDA | -555.81% | -908.47% | -370.80% | -151.51% | 92.01% |
| EPS Basic | -200.00% | -- | 100.00% | -33.33% | 66.67% |
| Normalized Basic EPS | -100.00% | -- | -- | -50.00% | 50.00% |
| EPS Diluted | -200.00% | -- | 100.00% | -33.33% | 66.67% |
| Normalized Diluted EPS | -100.00% | -- | -- | -50.00% | 50.00% |
| Average Basic Shares Outstanding | 25.01% | 0.00% | 0.10% | 0.14% | 0.45% |
| Average Diluted Shares Outstanding | 25.01% | 0.00% | 0.10% | 0.14% | 0.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
